[Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts

[Display omitted] Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is there...

Full description

Saved in:
Bibliographic Details
Published in:Actas dermo-sifiliográficas 2023-05, Vol.114 (5), p.T392-T401
Main Authors: Carrascosa, J.M., Vilarrasa, E., Belinchón, I., Herranz, P., Crespo, J., Guimerá, F., Olveira, A.
Format: Article
Language:English
Subjects:
Consensus
EHmet
Esteatosis hepática metabólica
Gastroenterology
Hepatotoxicidad
Hepatotoxicity
Humans
MAFLD
Metabolic-associated fatty liver disease
Non-alcoholic Fatty Liver Disease - complications
Patients
Psoriasis
Psoriasis - complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is therefore needed to enable early detection of liver disease coincident with psoriasis. Especially important is an analysis of risks and benefits of potentially hepatotoxic treatments. This consensus paper presents the recommendations of a group of experts in dermatology and hepatology regarding screening for MALFD as well as criteria for monitoring patients and referring them to hepatologists when liver disease is suspected. En los últimos años se están haciendo notables esfuerzos para entender la relación existente entre la psoriasis y la esteatosis hepática metabólica (EHmet). Este trastorno no solo se presenta con una mayor prevalencia en pacientes psoriásicos, sino que además se acompaña de una mayor gravedad. Con este precedente se evidencia la necesidad de establecer un protocolo de abordaje precoz de la enfermedad hepática en los pacientes con psoriasis. Asimismo, es de especial relevancia la evaluación del riesgo y del beneficio en referencia al uso de tratamientos con potencial hepatotóxico. En el presente manuscrito se exponen las recomendaciones de un panel de expertos en dermatología y hepatología para el cribado, el diagnóstico, la monitorización y los criterios de derivación en pacientes con psoriasis, en caso de sospecha de esteatosis hepática metabólica.
ISSN:0001-7310
2173-5778
DOI:10.1016/j.ad.2023.04.013